Executive Directors
Professor Jeremy Tavaré,
PhD (Chief Scientific Officer)
Professor Tavaré holds a Personal Chair in Biochemistry at
the University of Bristol. He is Director of the MRC Cell Imaging
Facility in Bristol and a member of the Physiological Medicines
and Infections Board at the UK Medical Research Council (MRC). He
has extensive grant funding from the MRC, Wellcome Trust and Diabetes
UK. In the past five years he has published 40 peer reviewed papers,
and has given in excess of 70 seminars in the UK, Europe, Japan
and the U.S. His expertise is in signal transduction and the use
of luminescent and fluorescent proteins for imaging signalling processes
occurring in living single cells.
Dr Paul England,
PhD, DSc (Chief Operating Officer)
Dr England has extensive experience in signal transduction, high
throughput screening and drug discovery in both academia and industry.
Following an academic career he joined Smith, Kline & French
in 1985. From 1994-1998 he was Vice-President Molecular Screening
Technologies at SmithKline Beecham, where he was responsible for
creating and managing the SB world-wide HTS department. From 1998-2000
he was Senior Vice President Research at Aurora BioSciences Corp.
in San Diego, with responsibility for both assay development and
screening.
Non-Executive Directors
Dr Jim Murray, MB, ChB, FRSM, MRCGP (Chairman of the Board)
Dr Jim Murray is Chief Executive of Hunter-Fleming
Ltd, having left Shire Pharmaceuticals, where he was co-founder
and Scientific Director, in 1999. Dr. Murray has over 25 years of
experience in the pharmaceutical industry, including 15 years with
Gist-Brocades (now Yamanouchi Europe) in the Netherlands, Belgium
and the UK. Positions held included Head of International Clinical
Research and Head of Strategic Planning when he was responsible
for Scientific Affairs in Japan, the Pacific Rim and Australia.
Dr Richard Seabrook, PhD, MBA
Dr Seabrook has been a business manager at Catalyst
BioMedica since 1998, following 10 years experience in the biopharmaceutical
sector, at the Centre for Applied Microbiology and Research (CAMR)
and at Quadrant Healthcare. At CAMR, Richard managed biopharmaceutical
and diagnostic projects, contributed to spin-out company formation
and helped to establish and run the business development group.
At Quadrant, he was commercial manager responsible for building
and managing the North American client base. Richard has extensive
negotiation, project management and marketing experience.
Senior Scientific Staff
Dr Laura Fletcher, PhD
Laura Fletcher gained a first class degree in Biochemistry at the
University of Bristol, during which time she was awarded a Science
Faculty Scholarship, the Celltech Prize for Molecular Biology and
the Garner Prize for Biochemistry. After spending a year in the
Department of Biochemistry at the University of Pennsylvania, Philadelpia,
she studied for her PhD in the laboratory of Professor Tavaré,
where she developed extensive skills in cell biology and fluorescent
microscopy. As one of the founding scientists, she has been working with ProXara since its incorporation.
|
